(Q51835125)

13 April 2018

title

Expression of erythropoietin receptor splice variants in human cancer. (English)

1 reference

13 April 2018

1 reference

Murat O Arcasoy

1

1 reference

13 April 2018

Xiaohong Jiang

series ordinal

2

1 reference

13 April 2018

Zishan A Haroon

series ordinal

3

1 reference

13 April 2018

language of work or name

English

0 references

publication date

1 August 2003

1 reference

13 April 2018

Biochemical and Biophysical Research Communications

published in

1 reference

13 April 2018

volume

307

1 reference

13 April 2018

issue

4

1 reference

13 April 2018

page(s)

999-1007

1 reference

13 April 2018

Expression cloning of the murine erythropoietin receptor

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901303-2

Structural design and molecular evolution of a cytokine receptor superfamily

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901303-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901303-2

inferred from DOI database lookup

7 January 2021

based on heuristic

A new hematopoietic growth factor receptor superfamily: structural features and implications for signal transduction

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901303-2

Crystallographic evidence for preformed dimers of erythropoietin receptor before ligand activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901303-2

Erythropoietin receptor activation by a ligand-induced conformation change

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901303-2

Signal transduction in the erythropoietin receptor system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901303-2

Erythropoietin has a mitogenic and positive chemotactic effect on endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901303-2

Human, rat, and mouse kidney cells express functional erythropoietin receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901303-2

Erythropoietin stimulates proliferation and interferes with differentiation of myoblasts.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901303-2

Erythropoietin acts as a trophic factor in neonatal rat intestine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901303-2

Recombinant human erythropoietin stimulates angiogenesis in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901303-2

Estrogen-dependent production of erythropoietin in uterus and its implication in uterine angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901303-2

Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901303-2

In vivo evidence that erythropoietin protects neurons from ischemic damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901303-2

Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901303-2

Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901303-2

Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signalling cascades

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901303-2

Immunohistochemical expression of erythropoietin and erythropoietin receptor in breast carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901303-2

Inhibition of erythropoietin signalling destroys xenografts of ovarian and uterine cancers in nude mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901303-2

Hypoxia-inducible erythropoietin signaling in squamous dysplasia and squamous cell carcinoma of the uterine cervix and its potential role in cervical carcinogenesis and tumor progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901303-2

Erythropoietin receptor expression in human melanoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901303-2

Erythropoietin stimulates proliferation of human renal carcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901303-2

Erythropoietin and G-CSF receptors in human tumor cells: expression and aspects regarding functionality.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901303-2

Purification and characterization of the yeast-expressed erythropoietin mutant Epo (R103A), a specific inhibitor of human primary hematopoietic cell erythropoiesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901303-2

Erythropoietin mediates terminal granulocytic differentiation of committed myeloid cells with ectopic erythropoietin receptor expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901303-2

A novel mutation in the erythropoietin receptor gene is associated with familial erythrocytosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901303-2

A truncated erythropoietin receptor that fails to prevent programmed cell death of erythroid cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901303-2

Role of c-jun in the inhibition of erythropoietin receptor-mediated apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901303-2

Dominant negative effect of a truncated erythropoietin receptor (EPOR-T) on erythropoietin-induced erythroid differentiation: possible involvement of EPOR-T in ineffective erythropoiesis of myelodysplastic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901303-2

Activation and inhibition of erythropoietin receptor function: role of receptor dimerization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901303-2

Oligomerization and scaffolding functions of the erythropoietin receptor cytoplasmic tail.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901303-2

Genetic heterogeneity of primary familial and congenital polycythemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901303-2

The intron 5-inserted form of rat erythropoietin receptor is expressed as a membrane-bound form

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901303-2

Prolactin receptor antagonists that inhibit the growth of breast cancer cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901303-2

Soluble receptors for cytokines and growth factors: generation and biological function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901303-2

Enzyme-linked immunosorbent assay detects a potential soluble form of the erythropoietin receptor in human plasma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901303-2

Functional significance of erythropoietin receptor expression in breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901303-2

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0006-291X(03)01303-2

1 reference

13 April 2018

PubMed ID

12878211

1 reference

13 April 2018